Perioperative care and diabetes
Authors:
Alena Šmahelová
Authors‘ workplace:
Centrum a subkatedra diabetologie FN a LF UK Hradec Králové
Published in:
Vnitř Lék 2015; 61(6): 563-566
Category:
Předneseno na mezioborovém sympoziu s postgraduálním zaměřením „Diabetik – společný pacient diabetologa a ortopeda“ 10. října 2014 v Hradci Králové.
Overview
The perioperative care of diabetic patients is specific due to the necessity of adequate glycaemic correction, as well as owing to the occurrence of complications not taking place in nondiabetic patients. The present antidiabetic treatment therefore mostly needs to be adjusted to the perioperative period, but this is largely not necessary in the case of small and short surgeries. The perioperative care of diabetic patients must be carefully organized and scheduled. The main rules include adequate monitoring of blood glucose and insulin therapy, provision of nutrition and surgery performance in the morning.
Key words:
antidiabetic treatment – perioperative care of the diabetic patient
Sources
1. Frisch A, Chandra P, Smiley D et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes care 2010; 33(8): 1783–1788.
2. Informace dostupné z WWW: <http//www.emedicine.medscape.com>.
3. Sebranek JJ, Lugli AK, Coursin DEB. Glycaemic control in the perioperative period. Br J Anaesth 2013; 111(Suppl 1): i18-i34. Dostupné z DOI: <http://dx.doi.org/10.1093/bja/aet381>.
4. Chien-Wei Hsu. Glycemic control in critically ill patients. World J Crit Care Med 2012; 1(1): 31–39.
5. Finfer S, Liu B, Chittock DR et al. NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367(12): 1108–1118.
6. Van den Berghe G, Wilmer A, Hermans G. Intensive Insulin Therapy in the Medical ICU. N Engl J Med 2006; 354(5): 449–461.
7. The NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367(12): 1108–1118.
8. Griesdale DE, de Souza RJ, van Dam RM et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180(8): 821–827.
9. Dhatariya K, Levy N, Kilvert A et al. Diabetes UK Position Statements and Care Recommendations. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med 2012; 29(4): 420–433.
10. American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care 2010; 33(Suppl 1): S11-S61. Erratum in Diabetes Care 2010; 33(3): 692.
11. Umpierrez GE, Smiley D, Jacobs S et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery). Diabetes Care 2011; 34(2): 256–261.
12. Gustafsson UO, Thorell A, Soop M et al. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg 2009; 96(11): 1358–1364.
13. Dronge AS, Perkal MF, Kancir S et al. Long-term Glycemic Control and Postoperative Infectious Complications. Arch Surg 2006; 141(4): 375–380.
14. Han HS, Kang SB. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics. Clin Orthop Surg 2013; 5(2): 118–123.
15. Sato H, Carvalho G, Sato T et al. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 2010; 95(9): 4338–4344.
16. Hudson CC, Welsby IJ, Phillips-Bute B et al. Cardiothoracic Anesthesiology Research Endeavors (C.A.R.E.) Group. Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth 2010; 57(6): 565–572.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2015 Issue 6
Most read in this issue
- Diagnosing and therapy of gout
- “Stressful holiday” – takotsubo cardiomyopathy
- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) – dabigatran etexilate, apixaban and rivaroxaban
- Alveolar echinococcosis – rare cystic disease of the liver – editorial